Theraclion S.A.
TCLIF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -8.1% | 141.8% | -47.5% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -353.5% | -377.7% | -708.4% | -49.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -323.3% | -270.9% | -627.5% | -193.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -304.3% | -317.6% | -534.6% | -142.5% |
| EPS Diluted | -0.065 | -0.073 | -0.052 | -0.026 |
| % Growth | 11.9% | -41.6% | -97.3% | – |
| Operating Cash Flow | – | -$0 | -$0 | -$0 |
| Capital Expenditures | – | -$0 | -$0 | $0 |
| Free Cash Flow | – | -$0 | -$0 | $0 |